C. David Nicholson - Nov 3, 2023 Form 4 Insider Report for Adverum Biotechnologies, Inc. (ADVM)

Role: Director
Signature: C. David Nicholson, by /s/ Ron A. Metzger, Attorney-in-Fact
Stock symbol: ADVM
Transactions as of: Nov 3, 2023
Transactions value $: $0
Form type: 4
Date filed: 11/6/2023, 07:54 PM
Previous filing: Jul 1, 2022
Next filing: Dec 29, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ADVM	Stock Option (Right to Buy)	Award	$0	+80K		$0.00	80K	Nov 3, 2023	Common Stock	80K	$0.93	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	1/3 of the total number of shares subject to the option vest and become exercisable on each anniversary of November 3, 2023 (the "Vesting Commencement Date"), such that all of the shares subject to the option shall become vested and exercisable as of the third anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service with the Issuer on each such vesting date.

Content

1/3 of the total number of shares subject to the option vest and become exercisable on each anniversary of November 3, 2023 (the "Vesting Commencement Date"), such that all of the shares subject to the option shall become vested and exercisable as of the third anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service with the Issuer on each such vesting date.